BioLineRx (BLRX) Profit After Tax Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 28.53% |
| Sep 30, 2025 | 26.70% |
| Jun 30, 2025 | -10.26% |
| Mar 31, 2025 | 22.62% |
| Dec 31, 2024 | 20.23% |
| Sep 30, 2024 | -8.13% |
| Jun 30, 2024 | -38.46% |
| Mar 31, 2024 | 35.33% |
| Dec 31, 2023 | -19.69% |
| Sep 30, 2023 | -20.43% |
| Jun 30, 2023 | 31.10% |
| Mar 31, 2023 | -14.43% |
| Dec 31, 2022 | 4.87% |
| Sep 30, 2022 | 1.12% |
| Jun 30, 2022 | 8.73% |
| Mar 31, 2022 | -0.31% |
| Dec 31, 2021 | -0.09% |
| Sep 30, 2021 | -5.69% |
| Jun 30, 2021 | 30.82% |
| Mar 31, 2021 | -23.91% |
| Dec 31, 2020 | -26.84% |
| Sep 30, 2020 | -23.22% |
| Jun 30, 2020 | 27.79% |
| Mar 31, 2020 | -9.04% |
| Dec 31, 2019 | -18.67% |
| Sep 30, 2019 | -41.27% |
| Jun 30, 2019 | 27.34% |
| Mar 31, 2019 | -23.82% |
| Dec 31, 2018 | -23.32% |
| Sep 30, 2018 | -19.64% |
| Jun 30, 2018 | 26.68% |
| Mar 31, 2018 | -11.99% |